Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate
- PMID: 10200992
- DOI: 10.1046/j.1523-1755.1999.00386.x
Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate
Abstract
Background: The abnormal control of parathyroid hormone secretion in chronic renal failure is attributed, in part, to down-regulation of the calcium-sensing receptor (CaR) in hyperplastic parathyroid tissue. The cause of this down-regulation is unknown. Here we examined the roles of uremia and parathyroid hyperplasia on parathyroid gland (PTG) CaR expression in the rat model of renal failure.
Methods: Rats made uremic by 5/6 nephrectomy were maintained for one month on diets containing 0.2% P (low phosphate), 0.5% P (normal phosphate) or 1.2% P (high phosphate); intact rats (controls) were maintained on the normal-phosphate diet.
Results: CaR mRNA was reduced only in uremic rats fed the high-phosphate diet (55% less than in controls, P < 0.05). Immunohistochemical staining revealed decreased CaR protein expression in uremic high-phosphate rat PTG compared with controls (41% decrease as determined by computer-assisted quantitation, P < 0.01). PTG size was increased in uremic rats fed the high-phosphate diet compared with controls (2.77 +/- 0.95 vs. 0.77 +/- 0.16 microgram/g body wt, P < 0.0001). There was no increase in PTG size in uremic rats fed the low-phosphate and normal-phosphate diets (0.92 +/- 0.31 and 1.01 +/- 0.31 micrograms/g) compared with controls (0.77 +/- 0.16 microgram/g body wt). Immunohistochemical staining for proliferating cell nuclear antigen in hyperplastic PTG from uremic rats showed that CaR was decreased primarily in areas of active cell proliferation.
Conclusion: These results suggest that CaR down-regulation cannot be attributed to uremia per se, but rather, is associated with parathyroid cell proliferation. Furthermore, dietary phosphate restriction prevents both the parathyroid hyperplasia and decreased CaR expression in renal failure.
Similar articles
-
Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.Kidney Int. 2001 Nov;60(5):1737-44. doi: 10.1046/j.1523-1755.2001.00027.x. Kidney Int. 2001. PMID: 11703591
-
Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.Nephrol Dial Transplant. 2010 Apr;25(4):1087-97. doi: 10.1093/ndt/gfp616. Epub 2009 Nov 23. Nephrol Dial Transplant. 2010. PMID: 19934096
-
Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.J Am Soc Nephrol. 2004 Oct;15(10):2579-87. doi: 10.1097/01.ASN.0000141016.20133.33. J Am Soc Nephrol. 2004. PMID: 15466262
-
Parathyroid growth and suppression in renal failure.Semin Dial. 2006 May-Jun;19(3):238-45. doi: 10.1111/j.1525-139X.2006.00161.x. Semin Dial. 2006. PMID: 16689976 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
FGF23 fails to inhibit uremic parathyroid glands.J Am Soc Nephrol. 2010 Jul;21(7):1125-35. doi: 10.1681/ASN.2009040427. Epub 2010 Apr 29. J Am Soc Nephrol. 2010. PMID: 20431039 Free PMC article.
-
A mathematical model of parathyroid gland biology.Physiol Rep. 2019 Apr;7(7):e14045. doi: 10.14814/phy2.14045. Physiol Rep. 2019. PMID: 30927339 Free PMC article.
-
Calcium receptor and regulation of parathyroid hormone secretion.Rev Endocr Metab Disord. 2000 Nov;1(4):307-15. doi: 10.1023/a:1026570518919. Rev Endocr Metab Disord. 2000. PMID: 11706745 Review.
-
Differential gene expression by oxyphil and chief cells of human parathyroid glands.J Clin Endocrinol Metab. 2012 Aug;97(8):E1499-505. doi: 10.1210/jc.2011-3366. Epub 2012 May 14. J Clin Endocrinol Metab. 2012. PMID: 22585091 Free PMC article.
-
Renal osteodystrophy.Rev Endocr Metab Disord. 2001 Apr;2(2):187-93. doi: 10.1023/a:1010058828232. Rev Endocr Metab Disord. 2001. PMID: 11705324 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources